Hermans, C., Ahuja, S., Alzahrani, H., Ay, C., Kampmann, P., Obaji, S., Susen, S., Tomuleasa, C., Vulpen, L. V., Nielsen, A. R. H., Rakhmatullin, I., Escuriola-Ettingshausen, C. (2025). From efficacy to experience: 52-week patient-reported outcomes with Mim8 in adolescents and adults with hemophilia A with or without inhibitors (FRONTIER2). Blood. https://doi.org/10.1182/blood-2025-540